Hepatitis B surface antigen (HBsAg) prevalence in Ghana
Ghana: Hepatitis B surface antigen (HBsAg) prevalence was 1.1% in 2024. ▼ Falling
Latest (2024)
1.1%
Change on year
unchanged
World rank
26th
of 194 countries
All-time high
1.9%
in 2015
All-time low
1.1%
in 2022
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Ghana, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Ghana recorded 1.1% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 42.1% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Ghana peaked at 1.9% in 2015 and was at its lowest, 1.1%, in 2022.
That places Ghana 26th out of 194 countries with data for 2024, putting it in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in Ghana, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.9% | — |
| 2016 | 1.9% | +0.0% |
| 2017 | 1.7% | -10.5% |
| 2018 | 1.6% | -5.9% |
| 2019 | 1.4% | -12.5% |
| 2020 | 1.4% | +0.0% |
| 2021 | 1.2% | -14.3% |
| 2022 | 1.1% | -8.3% |
| 2023 | 1.1% | +0.0% |
| 2024 | 1.1% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.7% | 1.4% | 1.9% | 5 |
| 2020s | 1.2% | 1.1% | 1.4% | 5 |
Countries ranked near Ghana
More health data for Ghana
- Un projection of annual infant deaths, annual growth rate -1.37 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6224 % change on previous year (2090)
- Heat deaths vs projected death rates 986.1 (2090)
- Un projection of annual infant deaths 8,361 (2100)
- Population ages 65 and above, female, annual growth rate 3.85 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.0209 units per person (2025)
- Population ages 65 and above, male, annual growth rate 4.25 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.017 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Ghana?
- Hepatitis b surface antigen (hbsag) prevalence in Ghana was 1.1% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Ghana?
- The highest recorded value was 1.9% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Ghana?
- The lowest recorded value was 1.1% in 2022.
- How does Ghana rank for hepatitis b surface antigen (hbsag) prevalence?
- Ghana ranks 26th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Ghana?
- Over the last ten years it is down 42.1%. The long-run trend across the full record is falling.
- Where does this Ghana data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).